The Zidovudine Capsules, cataloged under National Stock Number 6505-01-325-7690, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Glaxo Wellcome Inc. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 6 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-325-7690 |
| Primary Part Number | NDC00173-0108-56 |
| Item Name | Zidovudine Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Glaxo Wellcome Inc |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | UNIT DOSE |
| Primary Container Type | STRIP |
| Capsule Primary Container Content Quantity | 100.000 |
| Active Medicament Medicinal Strength | 100.000 MILLIGRAMS ZIDOVUDINE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00173-0108-56 PRIMARY | Glaxo Wellcome Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00173-0108-56 | 5/9 Secondary reference Burroughs Wellcome Co |
| NDC00081-0108-56 | 5/9 Secondary reference Burroughs Wellcome Co |
| NDC00173-0108-56 | 3/1 Design control — primary reference Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office |
| F90G054 | 5/1 Secondary reference Air Force Medical Logistics Office |
| RETROVIR CAPSULES | 5/9 Secondary reference Burroughs Wellcome Co |
| RETROVIR | 5/9 Secondary reference Burroughs Wellcome Co |
NSN 6505-01-325-7690 is a Zidovudine Capsules, manufactured by Glaxo Wellcome Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-325-7690 has 1 manufacturer part number on file: NDC00173-0108-56 (Glaxo Wellcome Inc).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-693-2628. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00173-0108-56: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Features Provided: UNIT DOSE; Primary Container Type: STRIP; Capsule Primary Container Content Quantity: 100.000. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.